Localization of differentially methylated CpGs in decitabine-treated BL cell lines and xenografts. Decitabine- and vehicle-treated cells and xenograft tumors were evaluated with Methyl-Capture sequencing as described above. Differentially methylated areas were mapped to the EBV genome using Integrative Genomics Viewer (Broad Institute; https://software.broadinstitute.org/software/igv). DMCs, differentially methylated cytosines.